Federal: Other MH Policy
Official titleOn National HIV Testing Day, SAMHSA Encourages Everyone to Take Back Your Health by Knowing Your HIV Status
Federal · Relevance score 15 of 100 (tangential). low impact.
This summary is informational and is not legal advice. Read the source text before acting on it.
What this policy change does.
- Jurisdiction
- Federal
- Published
- June 26, 2026
- Impact score
- 15 of 100, from analysis of the full text: tangential
- Primary source
- SAMHSA
Impact on your practice
This is a public health awareness campaign with minimal direct impact on therapist practice. It may be relevant for therapists working with HIV-positive populations or in substance use treatment, but does not affect policy, reimbursement, or licensing.
Key facts
- SAMHSA National HIV Testing Day awareness campaign
- Encourages HIV testing as part of preventive health
- Links HIV status knowledge to treatment connection
- Primarily a public awareness initiative
What it would mean for a practice.
This SAMHSA messaging creates an expectation—though not yet a mandate—that behavioral health treatment settings should integrate HIV testing into routine care, particularly for patients in substance use disorder (SUD), serious mental illness (SMI), and co-occurring disorder (COD) programs. For your practice, this means SAMHSA is signaling that HIV testing accessibility should become standard workflow, not optional. If you operate a SUD or dual-diagnosis program, you should anticipate that payers, accreditors, and funders may eventually tie reimbursement or licensing requirements to demonstrated HIV testing integration. Currently, this is a soft recommendation with no direct financial penalty, but the language—'SAMHSA encourages...treatment settings...to make HIV testing routine, low-barrier, and connected to care'—foreshadows policy direction. The clinical data presented (38,000 new diagnoses in 2024; 19% of people who inject drugs sharing syringes; 48% testing rate among that population; 17% of newly diagnosed adults reporting depression symptoms) establishes the rationale for why payers will eventually demand this integration. Solo practitioners and small agencies serving SUD or SMI populations should begin documenting whether you offer or refer for HIV testing and how you link positive cases to care; this documentation will become a compliance checkpoint. There is no immediate reimbursement impact, but practices that already integrate testing will have competitive advantage and reduced audit risk when such requirements eventually appear in managed care contracts or state Medicaid conditions of participation.
Background
SAMHSA's June 2026 National HIV Testing Day statement reflects a broader federal shift toward integrated behavioral health and infectious disease screening. The backdrop is stark: over 38,000 new HIV diagnoses annually, with significant overlap between substance use populations and undiagnosed HIV status. The 2024 data showing only 48% of people who inject drugs received an HIV test in the prior year indicates a testing gap despite expanded access. Equally important is SAMHSA's explicit acknowledgment of the mental health sequelae of HIV diagnosis—17% depression, 16% moderate-to-severe anxiety—which positions therapists as essential to the care continuum, not ancillary providers. This is a precursor to integrated care mandates: federal agencies are building the evidence base and organizational norm-setting before state Medicaid programs or CMS insert HIV testing requirements into behavioral health coverage rules.
What you should do
- If your practice serves SUD, SMI, or COD populations, audit your current HIV testing protocol: document whether testing is offered on-site, referred reliably, or absent. Begin developing or formalizing a referral pathway to CDC GetTested or local health department testing if you do not currently have one.
- Review your patient intake and ongoing assessment documentation to verify whether HIV status is collected or updated. This is not mandated yet, but will likely appear in future accreditation standards and payer requirements; establishing the habit now prevents future compliance gaps.
- If you are a practice director or agency head, include HIV testing accessibility in your next quality improvement or operational plan. This positions your organization proactively ahead of expected payer or regulatory requirements and improves patient outcomes.
- Train clinical staff on the connection between HIV diagnosis and behavioral health symptoms (depression, anxiety, substance use relapse risk). SAMHSA is emphasizing that therapists have a role in post-diagnosis mental health support; ensure your team can recognize and address this.
- Bookmark FindTreatment.gov and GetTested.gov resources and include them in your patient education materials and discharge planning, particularly for SUD and dual-diagnosis patients.
Notable excerpts
Treatment settings that serve people with SUD, SMI, and COD are important places to make HIV testing more accessible, support conversations about prevention, and connect people to appropriate HIV care and behavioral health services.
Among adults diagnosed with HIV, 17 percent reported experiencing symptoms of depression in the past year, and 16 percent experienced symptoms of moderate to severe anxiety.
SAMHSA encourages behavioral health providers, community partners, and recovery support service organizations to help make HIV testing routine, low-barrier, and connected to care.
View full source text
Read the original policy source.
Primary source text, linked directly.
- Analysis by
- Therapy Companion policy engine
- Confidence
- high
- Analyzed
- July 28, 2026
Related policy changes.
- Relevance score78 / 100
[US] SB4754: Primary and Behavioral Health Care Access Act of 2026
This federal bill could reshape behavioral health workforce, reimbursement, or access policy nationwide. Both chambers now have versions in committee—therapists should track this closely as it progresses.high impact - Relevance score75 / 100
STAT+: HHS presses ahead with effort to curb antidepressant use
Incoming federal clinical guidance on deprescribing could reshape how therapists collaborate with prescribers, increase referrals for therapy-based alternatives, and potentially create new practice opportunities—or reduce medication management referrals. Early insight into this guidance development is critical for practice planning.high impact - Relevance score72 / 100
Opinion: MAHA is rewriting the vocabulary of American mental health care
If HHS-promoted deprescribing becomes standard practice guidance, therapists may see shifts in referral patterns, patient expectations around medication, and potential new billing codes for medication management/tapering counseling. This represents a major philosophical shift in federal mental health approach.high impact - Relevance score72 / 100
[TN] SB1248: AN ACT to amend Tennessee Code Annotated, Title 4; Title 8; Title 33; Title 39; Title 49; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to mental health.
This omnibus bill has potential to reshape Tennessee's mental health landscape across multiple domains. Therapists should monitor committee review closely, as the 10 amended title sections suggest changes to licensing, insurance, workforce development, or scope of practice.high impact
Track what affects your practice.
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.